Data as of Apr 17
| +0.08 / +1.98%|
The 3 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 9.00, with a high estimate of 9.25 and a low estimate of 7.00. The median estimate represents a +117.92% increase from the last price of 4.13.
The current consensus among 3 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.